Cost of Revenue in USD of MediXall Group, Inc. from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
MediXall Group, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2022 to Q3 2024.
  • MediXall Group, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $16.6K, a 73.8% decline year-over-year.
  • MediXall Group, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $130K, a 30.9% decline year-over-year.
  • MediXall Group, Inc. annual Cost of Revenue for 2023 was $237K.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Cost of Revenue, Annual (USD)

MediXall Group, Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $130K $16.6K -$46.6K -73.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-09-08
Q2 2024 $177K $14.6K -$21K -59% Apr 1, 2024 Jun 30, 2024 10-Q 2025-06-05
Q1 2024 $198K $50.4K -$39K -43.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-19
Q4 2023 $237K $48.4K +$48.4K Oct 1, 2023 Dec 31, 2023 10-K 2025-01-27
Q3 2023 $188K $63.1K +$63.1K Jul 1, 2023 Sep 30, 2023 10-Q 2025-09-08
Q2 2023 $125K $35.6K +$35.6K Apr 1, 2023 Jun 30, 2023 10-Q 2025-06-05
Q1 2023 $89.4K $89.4K +$89.4K Jan 1, 2023 Mar 31, 2023 10-Q 2025-05-19
Q4 2022 $0 $0 Oct 1, 2022 Dec 31, 2022 10-K 2025-01-27
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2024-06-20
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2024-06-06
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2024-05-14

MediXall Group, Inc. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $237K +$237K Jan 1, 2023 Dec 31, 2023 10-K 2025-01-27
2022 $0 Jan 1, 2022 Dec 31, 2022 10-K 2025-01-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.